[go: up one dir, main page]

MXPA03001831A - Esteroles encapsulados dispersables en agua. - Google Patents

Esteroles encapsulados dispersables en agua.

Info

Publication number
MXPA03001831A
MXPA03001831A MXPA03001831A MXPA03001831A MXPA03001831A MX PA03001831 A MXPA03001831 A MX PA03001831A MX PA03001831 A MXPA03001831 A MX PA03001831A MX PA03001831 A MXPA03001831 A MX PA03001831A MX PA03001831 A MXPA03001831 A MX PA03001831A
Authority
MX
Mexico
Prior art keywords
starch
water
dispersible
sterols
phytosterols
Prior art date
Application number
MXPA03001831A
Other languages
English (en)
Spanish (es)
Inventor
Nicolas Auriou
Original Assignee
Novartis Nutrition Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Nutrition Ag filed Critical Novartis Nutrition Ag
Publication of MXPA03001831A publication Critical patent/MXPA03001831A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
MXPA03001831A 2000-09-01 2001-08-30 Esteroles encapsulados dispersables en agua. MXPA03001831A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021498.1A GB0021498D0 (en) 2000-09-01 2000-09-01 New formulation
PCT/EP2001/010044 WO2002017892A2 (fr) 2000-09-01 2001-08-30 Stérols encapsulés dispersables dans l'eau

Publications (1)

Publication Number Publication Date
MXPA03001831A true MXPA03001831A (es) 2003-06-04

Family

ID=9898673

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001831A MXPA03001831A (es) 2000-09-01 2001-08-30 Esteroles encapsulados dispersables en agua.

Country Status (17)

Country Link
EP (2) EP1749520A1 (fr)
JP (1) JP2004507492A (fr)
AT (1) ATE345783T1 (fr)
AU (1) AU2002213868A1 (fr)
BR (1) BR0113621A (fr)
CA (1) CA2419249A1 (fr)
CY (1) CY1106039T1 (fr)
DE (1) DE60124738T2 (fr)
DK (1) DK1315482T3 (fr)
ES (1) ES2277952T3 (fr)
GB (1) GB0021498D0 (fr)
HU (1) HUP0300878A3 (fr)
MX (1) MXPA03001831A (fr)
PL (1) PL359704A1 (fr)
PT (1) PT1315482E (fr)
WO (1) WO2002017892A2 (fr)
ZA (1) ZA200301097B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673383B2 (en) * 2001-03-26 2004-01-06 Unilever Patent Holdings Bv Method for improving the performance of a food product
US6773733B2 (en) 2001-03-26 2004-08-10 Loders Croklaan Usa Llc Structured particulate systems
US20030003131A1 (en) * 2001-06-22 2003-01-02 Matthew Dyer Method for manufacture of free-flowing powder containing water-dispersible sterols
US20060147523A1 (en) 2002-10-16 2006-07-06 Alan Fergusson Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
DE10253111A1 (de) * 2002-11-13 2004-05-27 Basf Ag Pulverförmige Phytosterol-Formulierungen
CA2536283A1 (fr) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Preparations pharmaceutiques possedant une solubilite accrue
BRPI0414628A (pt) * 2003-09-22 2006-11-07 Degussa Health & Nutrition Ame incorporação de fitoesteróis em aromatizantes
EP1708579B1 (fr) * 2004-01-30 2008-11-12 Unilever N.V. Particules comprenant des phytosteroles et produits alimentaires les comprenant
US20050233002A1 (en) * 2004-04-15 2005-10-20 Trubiano Paolo C Encapsulation of oxygen sensitive agents
ATE342338T1 (de) * 2004-06-04 2006-11-15 Procter & Gamble Verkapselte partikel
US20060034934A1 (en) * 2004-08-13 2006-02-16 Deguise Matthew L Agglomeration of sterol particles
WO2006025742A1 (fr) * 2004-09-02 2006-03-09 Quest International Services B.V. Compositions aromatisantes thermostables
JP4915717B2 (ja) * 2004-09-09 2012-04-11 花王株式会社 肥満予防・改善剤
JPWO2006095798A1 (ja) * 2005-03-09 2008-08-14 サンスター株式会社 フィトステロールを含んだリポソームを含有する抗癌用経口組成物、該リポソームによる癌の予防又は治療
JP2009519721A (ja) * 2005-12-20 2009-05-21 フォーブス メディ−テック インコーポレーテッド １種又はそれ以上のフィトステロール及び／又はフィトスタノール、又はその誘導体、及び高ｈｌｂ乳化剤を含む組成物。
US8309156B2 (en) 2005-12-20 2012-11-13 Pharmachem Laboratories, Inc. Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high HLB emulsifiers
JP4989956B2 (ja) * 2006-12-11 2012-08-01 松谷化学工業株式会社 粉末化植物ステロールエステル製剤、その製造方法及びこれを含む飲食品
JP2011505155A (ja) * 2007-12-05 2011-02-24 ディーエスエム アイピー アセッツ ビー．ブイ． 脂溶性活性成分の微粉砕状調合物
KR20100097665A (ko) * 2007-12-05 2010-09-03 디에스엠 아이피 어셋츠 비.브이. 지용성 활성 성분의 분말 제형
EP2067410A1 (fr) * 2007-12-07 2009-06-10 Cognis IP Management GmbH Dispersion contenant un stérol dispersable dans l'eau
CN102292110A (zh) * 2009-02-13 2011-12-21 日新化成株式会社 硬胶囊
ES2374780A1 (es) * 2009-12-30 2012-02-22 José Javier Villa Cervera Procedimiento de fabricación de agua de beber, agua mineral, agua medicinal o similar, caracterizada porque incluye esteroles vegetales-fitoesteroles. la bebida contiene de 0.1 a 3 g litro de esteroles vegetales.
EP2658638B1 (fr) 2010-12-28 2014-09-03 Unilever N.V. Procédé pour la production d'une émulsion
US20120282368A1 (en) * 2011-05-03 2012-11-08 Brandeis University Amphiphilic sterol/fat-based particles
JP6092579B2 (ja) * 2012-11-07 2017-03-08 理研ビタミン株式会社 粉末状植物ステロール組成物およびその製造方法
CN104822276A (zh) * 2012-11-07 2015-08-05 理研维他命股份有限公司 粉末状植物甾醇组合物及其制造方法
JP6092580B2 (ja) * 2012-11-07 2017-03-08 理研ビタミン株式会社 粉末状植物ステロール組成物およびその製造方法
WO2019030442A1 (fr) * 2017-08-07 2019-02-14 Elicit Plant Composition a base de polyol(s) et de sterol(s) pour usage dans le domaine agricole
FR3069757B1 (fr) * 2017-08-07 2021-07-23 Innovi Production Composition a base de sterols
US20220312762A1 (en) * 2019-09-06 2022-10-06 The Texas A&M University System Use of encapsulated sterols to modify growth of crops, control, agricultural pests and as non-toxic pre-emergent herbicides
WO2023057640A1 (fr) 2021-10-08 2023-04-13 Elicit Plant Composition agricole à base de phytostérol et son utilisation
CN115969036B (zh) * 2023-01-10 2024-05-07 丰益油脂科技有限公司 植物甾醇颗粒物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3881005A (en) * 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof
JPS62186936A (ja) 1986-02-13 1987-08-15 Asahi Denka Kogyo Kk ステリン乳化乃至可溶化組成物
US5405615A (en) 1991-09-17 1995-04-11 Micro Vesicular Systems, Inc. Sucrose distearate lipid vesicles
WO1999018977A1 (fr) 1997-10-16 1999-04-22 Medical Isotopes Inc. Glycosides de phytosterols facilement absorbables traitant l'hypercholesterolemie
IN185730B (fr) * 1998-02-19 2001-04-14 Mcneil Ppc Inc

Also Published As

Publication number Publication date
JP2004507492A (ja) 2004-03-11
DE60124738D1 (de) 2007-01-04
WO2002017892A3 (fr) 2002-05-16
WO2002017892A2 (fr) 2002-03-07
DK1315482T3 (da) 2007-04-02
HUP0300878A3 (en) 2008-03-28
ES2277952T3 (es) 2007-08-01
PL359704A1 (en) 2004-09-06
DE60124738T2 (de) 2007-09-13
CY1106039T1 (el) 2011-04-06
EP1315482B1 (fr) 2006-11-22
PT1315482E (pt) 2007-02-28
CA2419249A1 (fr) 2002-03-07
BR0113621A (pt) 2003-07-22
AU2002213868A1 (en) 2002-03-13
HUP0300878A2 (hu) 2003-09-29
EP1315482A2 (fr) 2003-06-04
EP1749520A1 (fr) 2007-02-07
GB0021498D0 (en) 2000-10-18
ATE345783T1 (de) 2006-12-15
ZA200301097B (en) 2004-04-21

Similar Documents

Publication Publication Date Title
PL359704A1 (en) Water-dispersible encapsulated sterols
MXPA02001741A (es) Procedimiento para generar informacion del hueco de ascensor que sirve a un mando de ascensor.
AU2002223504A1 (en) Heterologous expression of taxanes
EP1223474B8 (fr) Procédé pour produire de la cire d'ester
HUP0100531A3 (en) Crystalline base of citalopram, method for producing it and medicament containing the same
WO2004041241A3 (fr) Structure implantable pour la liberation prolongee et controlee d'un principe actif
AU1434799A (en) Implant made of a reabsorbable ceramic material
AU2001296514A1 (en) Prosthesis having an external support structure and method of making the same
GB2381840A (en) Gearbox
IL135466A0 (en) Enzymatic modification of sterols
HUP0104776A3 (en) Method of preparing delta-9-tetrahydrocannabinol esters
NO994233D0 (no) Sterol-estere i faste, tabletterte doseringsformer
AU2001293753A1 (en) Method for the production of macrocyclic esters
AU2001268940A1 (en) Method for controlling the formation of a downlink beam
MXPA03004614A (es) Material estabilizado de crepado posterior y metodo para producir el mismo.
AU2002231683A1 (en) Method of producing alk-3-ene-1-ols
AU2000255759A1 (en) The production method of transgenic porcine producing human erythropoietin and the transgenic porcine
AU2001273333A1 (en) A method, an apparatus, and a composition for customizing the combination of fragrances
AU2002353123A1 (en) Method of making trimethylene carbonate
AU2002211285A1 (en) Method of making nanoshells
AU4124101A (en) Method of making silver-contained candle
AU6352301A (en) Method of synthesizing glyceryl mono-esters
AU2000261768A1 (en) An improved process for the preparation of docetaxel
AU7115100A (en) Methods and compositions for production of floral scent compounds
AU2002346714A1 (en) Method of making trimethylene carbonate

Legal Events

Date Code Title Description
FA Abandonment or withdrawal